手术路径与低危宫颈癌肿瘤结局的关联
基于加拿大安大略省2006至2017年903例接受根治性子宫切除术的宫颈癌患者,按SHAPE标准分层为低危和高危组,采用重叠加权倾向评分生存模型分析。低危组(N=621)微创与开腹手术在全因死亡、宫颈癌死亡和复发上无显著差异;高危组(N=282)微创手术与全因死亡、宫颈癌死亡和复发风险显著增加相关。
要点
- 低危宫颈癌(浸润深度<10mm且肿瘤直径≤20mm)微创根治性子宫切除术未显示不良肿瘤结局。
- 高危宫颈癌微创手术与全因死亡、宫颈癌死亡及复发风险显著增加相关。
- 低危组中复发和死亡事件不常见,需更多研究确认微创手术安全性。
核心结论
- 手术路径与肿瘤结局的关系可能因疾病风险组而异。
- 低危患者中微创根治性子宫切除术可能不增加不良肿瘤结局,但该亚组复发和死亡不常见。
- 需进一步研究确认严格SHAPE标准定义的低危人群中微创手术的安全性。
研究设计与样本
- 基于人群的回顾性队列研究,纳入2006至2017年加拿大安大略省903例由妇科肿瘤医生行初次根治性子宫切除术的宫颈癌患者。
- 按SHAPE病理标准分为低危组(浸润深度<10mm且最大肿瘤直径≤20mm,N=621)和高危组(浸润深度≥10mm或最大肿瘤直径>20mm,N=282)。
- 采用重叠加权倾向评分生存模型分析,校正人口学、临床和病理因素。
主要发现
- 中位年龄44岁(四分位距38-53),中位随访10年(四分位距7-13)。
- 低危组微创对比开腹根治性子宫切除术:全因死亡HR 0.88(95%CI 0.39-2.01;P=.76),宫颈癌死亡HR 1.15(95%CI 0.27-4.87;P=.85),复发HR 0.88(95%CI 0.4-1.91;P=.74)。
- 高危组微创对比开腹根治性子宫切除术:全因死亡HR 3.22(95%CI 1.37-7.58;P=.008),宫颈癌死亡HR 4.88(95%CI 1.50-15.83;P=.008),复发HR 2.32(95%CI 1.01-5.34;P=.048)。
临床怎么用
- 对符合SHAPE严格标准的低危宫颈癌患者,微创根治性子宫切除术可能是可接受的选择,但需个体化评估。
- 高危宫颈癌患者应优先考虑开腹根治性子宫切除术以降低复发和死亡风险。
局限性
- 回顾性队列设计可能存在残余混杂。
- 低危组复发和死亡事件数较少,统计效能有限。
- 结果需在严格SHAPE标准定义的低危人群中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent randomized evidence suggesting that simple hysterectomy is non-inferior to radical hysterectomy in cervical cancer patients with low-risk disease has invigorated questions about the safety of a minimally invasive approach in this population. OBJECTIVE: To determine whether the association between surgical approach and oncologic outcomes varied by disease risk group. STUDY DESIGN: Population-based retrospective cohort study of cervical cancer patients undergoing primary radical hysterectomy by a gynecologic oncologist from 2006 to 2017 in Ontario, Canada. Analyses were stratified by disease risk group, with patients classified as low-risk (depth of invasion <10 mm and maximum tumor diameter ≤20 mm) or high-risk (depth of invasion ≥10 mm or maximum tumor diameter >20 mm) according to pathologic Canadian Cancer Trials Group CX.5 Simple Hysterectomy and Pelvic Node Assessment (SHAPE) criteria. Overlap propensity score‑weighted survival models were used to examine the association between surgical approach and oncologic outcomes, adjusting for demographic, clinical, and pathologic factors. RESULTS: We identified 903 patients with median age 44 years (interquartile range, 38-53) and follow-up 10 years (interquartile range, 7-13). In low-risk patients (N=621), minimally invasive radical hysterectomy was not associated with all-cause death (hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.39-2.01; P=.76), cervical cancer death (HR, 1.15; 95% CI, 0.27-4.87; P=.85), or recurrence (HR, 0.88; 95% CI, 0.4-1.91; P=.74) compared to open radical hysterectomy. In high-risk patients (N=282), minimally invasive radical hysterectomy was associated with significantly increased all-cause death (HR, 3.22; 95% CI, 1.37-7.58; P=.008), cervical cancer death (HR, 4.88; 95% CI, 1.50-15.83; P=.008), and recurrence (HR, 2.32; 95% CI, 1.01-5.34; P=.048) compared to open radical hysterectomy. CONCLUSION: The relationship between surgical approach and oncologic outcomes appeared to vary by disease risk group. Minimally invasive radical hysterectomy may not be associated with adverse oncologic outcomes in patients with low-risk disease, but recurrence and death were uncommon in this subgroup. Additional studies are needed to confirm whether minimally invasive surgery remains safe in a low-risk population defined by strict SHAPE criteria.
引用
- Cusimano MC, Poxon A, Gien LT, et al. Association of surgical approach with oncologic outcomes in low-risk cervical cancer. Am J Obstet Gynecol. 2026. PMID: 42401251. doi:10.1016/j.ajog.2026.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。